Hi Jov
Great post. yes - I agree. Only thing I would add - as long as the Ph 1 with Blincyto shows reasonable clinical effectiveness, then I think in the Phase 2 for OnCARlytics they will include a Blincyto arm along with the Azer-Cel arm. The reason: if the Ph 1 trial tells them that OnCARlytics does work with Blincyto, it would make sense to get further proof of that at Phase 2 level.
Dropping Blincyto entirely would be putting all the OnCARlytics eggs into the Azer-Cel basket. OnCARlytics should work with Azer-Cel (and maybe even better than with Blincyto) - but they won't really know that until they do the trial, so I think they will do both.
Cheers
Dave
Hi JovGreat post. yes - I agree. Only thing I would add - as...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $464.8M | |||
| Open | High | Low | Value | Volume |
| 6.4¢ | 6.5¢ | 6.3¢ | $505.8K | 7.988M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 747700 | 6.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.4¢ | 1065440 | 14 |
View Market Depth
| Last trade - 10.48am 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.4¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 6.4¢ | 6.5¢ | 6.3¢ | 6588763 | ||
| Last updated 11.13am 04/06/2024 ? | |||||
| IMU (ASX) Chart |